E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosis

Introduction: Evidence suggests that e-cigarette use (vaping) increases cardiovascular disease risk, but decades are needed before people who vape would develop pathology. Thus, murine models of atherosclerosis can be utilized as tools to understand disease susceptibility, risk and pathogenesis. Mor...

Full description

Bibliographic Details
Main Authors: Bayan Alakhtar, Cynthia Guilbert, Nivetha Subramaniam, Vincenza Caruana, Kiran Makhani, Carolyn J. Baglole, Koren K. Mann
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Toxicology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/ftox.2023.1244596/full
_version_ 1797387721429221376
author Bayan Alakhtar
Cynthia Guilbert
Nivetha Subramaniam
Vincenza Caruana
Vincenza Caruana
Vincenza Caruana
Kiran Makhani
Carolyn J. Baglole
Carolyn J. Baglole
Carolyn J. Baglole
Carolyn J. Baglole
Koren K. Mann
Koren K. Mann
Koren K. Mann
author_facet Bayan Alakhtar
Cynthia Guilbert
Nivetha Subramaniam
Vincenza Caruana
Vincenza Caruana
Vincenza Caruana
Kiran Makhani
Carolyn J. Baglole
Carolyn J. Baglole
Carolyn J. Baglole
Carolyn J. Baglole
Koren K. Mann
Koren K. Mann
Koren K. Mann
author_sort Bayan Alakhtar
collection DOAJ
description Introduction: Evidence suggests that e-cigarette use (vaping) increases cardiovascular disease risk, but decades are needed before people who vape would develop pathology. Thus, murine models of atherosclerosis can be utilized as tools to understand disease susceptibility, risk and pathogenesis. Moreover, there is a poor understanding of how risk factors for atherosclerosis (i.e., hyperlipidemia, high-fat diet) intersect with vaping to promote disease risk. Herein, we evaluated whether there was early evidence of atherosclerosis in an inducible hyperlipidemic mouse exposed to aerosol from commercial pod-style devices and e-liquid.Methods: Mice were injected with adeno-associated virus containing the human protein convertase subtilisin/kexin type 9 (PCSK9) variant to promote hyperlipidemia. These mice were fed a high-fat diet and exposed to room air or aerosol derived from JUUL pods containing polyethylene glycol/vegetable glycerin (PG/VG) or 5% nicotine with mango flavoring for 4 weeks; this timepoint was utilized to assess markers of atherosclerosis that may occur prior to the development of atherosclerotic plaques.Results: These data show that various parameters including weight, circulating lipoprotein/glucose levels, and splenic immune cells were significantly affected by exposure to PG/VG and/or nicotine-containing aerosols.Discussion: Not only can this mouse model be utilized for chronic vaping studies to assess the vascular pathology but these data support that vaping is not risk-free and may increase CVD outcomes later in life.
first_indexed 2024-03-08T22:29:11Z
format Article
id doaj.art-342f357089b74edf812ca2357197e51b
institution Directory Open Access Journal
issn 2673-3080
language English
last_indexed 2024-03-08T22:29:11Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Toxicology
spelling doaj.art-342f357089b74edf812ca2357197e51b2023-12-18T06:58:08ZengFrontiers Media S.A.Frontiers in Toxicology2673-30802023-12-01510.3389/ftox.2023.12445961244596E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosisBayan Alakhtar0Cynthia Guilbert1Nivetha Subramaniam2Vincenza Caruana3Vincenza Caruana4Vincenza Caruana5Kiran Makhani6Carolyn J. Baglole7Carolyn J. Baglole8Carolyn J. Baglole9Carolyn J. Baglole10Koren K. Mann11Koren K. Mann12Koren K. Mann13Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, CanadaLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, CanadaDivision of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, CanadaLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, CanadaResearch Institute of the McGill University Health Centre, Montreal, QC, CanadaDepartment of Pharmacology and Therapeutics, McGill University, Montreal, QC, CanadaDivision of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, CanadaDivision of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, CanadaResearch Institute of the McGill University Health Centre, Montreal, QC, CanadaDepartment of Pharmacology and Therapeutics, McGill University, Montreal, QC, CanadaDepartment of Pathology, McGill University, Montreal, QC, CanadaDivision of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, CanadaLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, CanadaDepartment of Pharmacology and Therapeutics, McGill University, Montreal, QC, CanadaIntroduction: Evidence suggests that e-cigarette use (vaping) increases cardiovascular disease risk, but decades are needed before people who vape would develop pathology. Thus, murine models of atherosclerosis can be utilized as tools to understand disease susceptibility, risk and pathogenesis. Moreover, there is a poor understanding of how risk factors for atherosclerosis (i.e., hyperlipidemia, high-fat diet) intersect with vaping to promote disease risk. Herein, we evaluated whether there was early evidence of atherosclerosis in an inducible hyperlipidemic mouse exposed to aerosol from commercial pod-style devices and e-liquid.Methods: Mice were injected with adeno-associated virus containing the human protein convertase subtilisin/kexin type 9 (PCSK9) variant to promote hyperlipidemia. These mice were fed a high-fat diet and exposed to room air or aerosol derived from JUUL pods containing polyethylene glycol/vegetable glycerin (PG/VG) or 5% nicotine with mango flavoring for 4 weeks; this timepoint was utilized to assess markers of atherosclerosis that may occur prior to the development of atherosclerotic plaques.Results: These data show that various parameters including weight, circulating lipoprotein/glucose levels, and splenic immune cells were significantly affected by exposure to PG/VG and/or nicotine-containing aerosols.Discussion: Not only can this mouse model be utilized for chronic vaping studies to assess the vascular pathology but these data support that vaping is not risk-free and may increase CVD outcomes later in life.https://www.frontiersin.org/articles/10.3389/ftox.2023.1244596/fulle-cigaretteatherosclerosisvapingmouse modelhyperlipidaemia
spellingShingle Bayan Alakhtar
Cynthia Guilbert
Nivetha Subramaniam
Vincenza Caruana
Vincenza Caruana
Vincenza Caruana
Kiran Makhani
Carolyn J. Baglole
Carolyn J. Baglole
Carolyn J. Baglole
Carolyn J. Baglole
Koren K. Mann
Koren K. Mann
Koren K. Mann
E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosis
Frontiers in Toxicology
e-cigarette
atherosclerosis
vaping
mouse model
hyperlipidaemia
title E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosis
title_full E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosis
title_fullStr E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosis
title_full_unstemmed E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosis
title_short E-cigarette exposure causes early pro-atherogenic changes in an inducible murine model of atherosclerosis
title_sort e cigarette exposure causes early pro atherogenic changes in an inducible murine model of atherosclerosis
topic e-cigarette
atherosclerosis
vaping
mouse model
hyperlipidaemia
url https://www.frontiersin.org/articles/10.3389/ftox.2023.1244596/full
work_keys_str_mv AT bayanalakhtar ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT cynthiaguilbert ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT nivethasubramaniam ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT vincenzacaruana ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT vincenzacaruana ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT vincenzacaruana ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT kiranmakhani ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT carolynjbaglole ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT carolynjbaglole ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT carolynjbaglole ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT carolynjbaglole ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT korenkmann ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT korenkmann ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis
AT korenkmann ecigaretteexposurecausesearlyproatherogenicchangesinaninduciblemurinemodelofatherosclerosis